Alaunos Therapeutics (TCRT) Receivables - Other (2020 - 2021)
Alaunos Therapeutics (TCRT) has disclosed Receivables - Other for 2 consecutive years, with $1.1 million as the latest value for Q3 2021.
- For the quarter ending Q3 2021, Receivables - Other changed N/A year-over-year to $1.1 million, compared with a TTM value of $1.1 million through Sep 2021, changed N/A, and an annual FY2020 reading of $4.7 million, changed N/A over the prior year.
- Receivables - Other was $1.1 million for Q3 2021 at Alaunos Therapeutics, down from $7.6 million in the prior quarter.
- Across five years, Receivables - Other topped out at $7.6 million in Q2 2021 and bottomed at $1.1 million in Q3 2021.